Lyme & Other Tick-Borne Diseases: 2nd Rocky Mountain Forum

2nd Rocky Mountain Forum Agenda

Speaker Bios:


Patricia V. Smith
President, Lyme Disease Association; Columbia U. Lyme & TBD Research Center Advisory Panel; Congressionally Directed Medical Research Program Panel; FDA PESP Partner

Pat is a Monmouth University graduate, and is beginning her 21st year as President of the all-volunteer run national non-profit Lyme Disease Association, LDA. She is a member of: Columbia University’s Lyme & Tick-Borne Diseases Research Center Advisory Committee; Programmatic Panel Member for the Tick-Borne Diseases Research Program in the Department of Defense’s Congressionally Directed Medical Research Program; Member of the Food & Drug Administration’s (FDA) PESP Partnership to promote avoidance of tick exposure and, Member of the Tick IPM Working Group with federal and non-federal members, from the IPM Institute of North America, to eradicate tick-borne diseases. She has twice testified before Congress and is former chair of the NJ Governor’s Lyme Disease Advisory Council and she is a former officer for the International Lyme & Associated Diseases Society, a professional medical society. To see Full Bio and compete list of Pat’s accomplishments and publications please visit www.lymediseaseassocitaion.org.


 Elizabeth Maloney, MD
Physician, Co-author of ILADS 2014 Lyme Treatment Guidelines, Founder of Partnership for Tick-Borne Diseases Education (PTDE) & author of evidence based CME courses on TBD’s.

Dr. Maloney is a family physician from Wyoming, MN. She graduated from the University of MN Medical School in 1986 and completed her residency in family medicine at the University in 1989. She is a member of the American Academy of Family Practice, the Minnesota Academy of Family Practice and the International Lyme and Associated Diseases Society (ILADS).

For the past ten years, Dr. Maloney has been focused on educating the physicians and other healthcare professionals about tick-borne illnesses. She has authored accredited, evidence-based CME courses on Lyme disease, including several modules that are available online at www.LymeCME.info. She frequently speaks at medical conferences across the US and she’s authored or co-authored several papers on Lyme, including the ILADS Lyme treatment guidelines. Dr. Maloney founded Partnership for Tick-borne Diseases Education (PTDE) in 2015.  PTDE is a 501(c)(3) nonprofit organization specifically dedicated to creating education materials and content on TBDs for medical professionals and the public. PTDE’s website, www.PartnershipForTick-borneDiseasesEducation.org, is filled with a wide array of scientifically-based videos, handouts and facts on TBDs.


David Martz, MD
Dr. David Martz Colorado Physician, CU Assistant Clinical Professor, Researcher, and Former ILADS Board Member

Dr. David Martz is a board certified community physician who practiced Internal Medicine-Hematology-Oncology for 30 years (1970-2000) in Colorado Springs. He trained in Internal Medicine and Hematology at Washington University and Stanford University after getting his MD at the Colorado University Health Sciences Center (CUHSC) He was an assistant professor of clinical medicine at CUHSC in Denver for over 20 years, and a member of the Admissions Committee for over 10 years. He was the 1994-1995 President of the Colorado Medical Society, and the 2011 recipient of the Invisible Disabilities Association Research Honors Award. As a Coloradan, his Lyme disease experience was quite limited until April, 2003, when he acquired ALS, which was accompanied by Lyme-like systemic symptoms. His subsequent diagnosis, treatment, and remarkable response is detailed in a 2006 Acta Neurologica Scandanavia publication. He devoted the next 2 1/2 years to clinical study of extended antibiotic treatment for ALS as well as “Chronic Lyme Disease”, with many patients experiencing good-excellent response and minimal side effects. Born out of his personal experience with ALS, Dr. Martz has a passion to discover possible treatments for patients living with degenerative neurological illnesses. He is now fully retired and lives with his wife in Colorado Springs.


Jyotsna Shah, Ph.D., CCLD, MBA
President and Laboratory Director of IGeneX Clinical Laboratory 

Dr. Jyotsna Shah is the President and Laboratory Director of IGeneX Clinical Laboratory, Palo Alto, CA. Dr. Shah has over 40 years of research experience in immunology, molecular biology and microbiology. She got her B.Sc. and M.Sc. in Biological Sciences from UK and her Ph.D. in diagnostic immunology from Nairobi University, Kenya. She then joined International Laboratory for Research on Animal Diseases (ILRAD) as a post-doctoral scientist where she started the first DNA sequencing laboratory in E. Africa. On completion of her fellowship, she joined Harvard University, Department of Tropical Medicine, Boston as a research fellow and continued work on development of molecular tools for diagnosis of parasitic diseases. Since then she has worked at several Biotechnology companies, mostly involved in development of novel molecular technologies for diagnosis of infectious diseases. She is a world expert on use of Fluorescent in Situ Hybridization (FISH) technique for direct detection of pathogens in clinical samples. She has many publications and over 20 patents. She joined IGeneX as the Director of Research and Development in 1997. She introduced the first Fluorescent In Situ Hybridization (FISH) test for Babesia and also set up the PCR department for tick-borne diseases. Since April 2003 she has been the Laboratory Director (clinical and research). She represents IGeneX at local and international meetings. Under her guidance, the laboratory has developed an excellent QA program. Because of her scientific guidance IGeneX has become one of the leading reference laboratory for diagnosis of tick-borne diseases in the world. For more about Dr. Shah and IGeneX Clinical Laboratory visit www.igenex.com.


Dr. Heather Szerlong, Ph.D.
Founder and CEO of Ticknology, LLC.

Dr. Heather Szerlong is a Colorado native and founder of Ticknology, LLC. Her laboratory offers tick testing services that provide reliable, accurate and timely information to persons at risk from tick bites. Her broader mission is to build a network of scientists and educators that focus on the current challenges facing the fight against Lyme disease and other emerging tick-borne illnesses.  Dr. Szerlong earned a B.A. at the University of Colorado and a Ph.D. from the Department of Oncological Sciences at the University of Utah in Salt Lake City. She then moved back to Colorado where she was awarded an American Heart Association Post-Doctoral Fellowship at Colorado State University.  In 2012, Dr. Szerlong became certified as a Technologist in Molecular Biology from the American Society for Clinical Pathology (ASCP) while researching metabolic disease at the Biochemical Genetics Laboratory at Children’s Hospital Colorado in Denver. Dr. Szerlong also holds a Research Scientist position in the Department of Biomedical Sciences at Colorado State University in Fort Collins, CO. She has described much of her research in both peer-reviewed scientific journals and reference work including a book chapter in Methods in Molecular Biology and entry in the Encyclopedia of Biophysics. Dr. Szerlong has over 20 years of laboratory experience and is an expert in the areas of biology, protein and nucleic acid biochemistry, genetics and molecular diagnostics. For more on Dr. Szerlong and Ticknology, LLC visit www.ticknology.org